Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · NRC HEALTH (NRC)

NRC Health Q3 revenue rises 11% to $38.4 million; diluted EPS $0.21

Positive Impact 3 of 5 earnings Written later

NRC Health reported third-quarter 2026 revenue of $38.4 million, up 11% from $34.6 million a year earlier, and diluted EPS of $0.21 versus $0.18. Adjusted EBITDA was $10.9 million, roughly flat year over year, and its margin fell to 28% from 31%. Nine-month net income fell to $4.6 million from $9.8 million, and the company declared a $0.16 quarterly dividend.

Key points

  • Q3 2026 revenue $38.4 million, up 11% from $34.6 million; TRCV $154.1 million, up 9%
  • Q3 2026 net income $4.7 million and diluted EPS $0.21, versus $4.1 million and $0.18 in Q3 2025
  • Nine-month 2026 net income $4.6 million versus $9.8 million, with diluted EPS $0.20 versus $0.43
  • Quarterly dividend of $0.16 per share, payable January 8, 2027, to holders of record December 29, 2026

The filing

CompanyNRC HEALTH (NRC)
Form8-K, current report
Filed with the SECOct 27, 2026, 4:02 PM ET
Accession number0001437749-26-033639

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:51 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 27, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.